Intelligent Antibody Discovery


Abeome Closes $2M Angel Round

Athens, GA – Abeome Corporation announced today the closing of a $2M Angel Round.  The offering was oversubscribed.

About Abeome: Abeome is a privately-held antibody discovery company focused on the high throughput selection, analysis and synthesis of monoclonal antibodies with a primary objective to develop best-in-class products for the therapeutic antibody market – the fastest growing segment of global drug sales.